Literature DB >> 20505255

Host genetic factors in susceptibility to HIV-1 infection and progression to AIDS.

Koushik Chatterjee1.   

Abstract

HIV-1 infection has rapidly spread worldwide and has become the leading cause of mortality in infectious diseases. The duration for development of AIDS (AIDS progression) is highly variable among HIV-1 infected individuals, ranging from 2-3 years to no signs of AIDS development in the entire lifetime. Several factors regulate the rate at which HIV-1 infection progresses to AIDS. Host genetic factors play an important role in the outcome of such complex or multifactor diseases as AIDS and are also known to regulate the rate of disease progression. This review focuses on the major host genes reported to affect the progression to AIDS in HIV-1 infected individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505255     DOI: 10.1007/s12041-010-0003-4

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  103 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2.

Authors:  S H Kim; B Cohen; D Novick; M Rubinstein
Journal:  Gene       Date:  1997-09-01       Impact factor: 3.688

3.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

4.  Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort.

Authors:  G Diop; T Hirtzig; H Do; C Coulonges; A Vasilescu; T Labib; J-L Spadoni; A Therwath; M Lathrop; F Matsuda; J-F Zagury
Journal:  Biomed Pharmacother       Date:  2006-08-31       Impact factor: 6.529

5.  Global distribution of the CCR5 gene 32-basepair deletion.

Authors:  J J Martinson; N H Chapman; D C Rees; Y T Liu; J B Clegg
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

Review 6.  Considering genetic profiles in functional studies of immune responsiveness to HIV-1.

Authors:  M Carrington; G Nelson; S J O'Brien
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

Review 7.  Cytokines in autoimmunity.

Authors:  F M Brennan; M Feldmann
Journal:  Curr Opin Immunol       Date:  1996-12       Impact factor: 7.486

8.  Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure.

Authors:  W A Paxton; S R Martin; D Tse; T R O'Brien; J Skurnick; N L VanDevanter; N Padian; J F Braun; D P Kotler; S M Wolinsky; R A Koup
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

9.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

10.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.

Authors:  A G Wilson; N de Vries; F Pociot; F S di Giovine; L B van der Putte; G W Duff
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Unravelling the mechanisms of durable control of HIV-1.

Authors:  Bruce D Walker; Xu G Yu
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

2.  MBL2 genetic polymorphisms and HIV-1 mother-to-child transmission in Zambia.

Authors:  Luisa Zupin; Vania Polesello; Ludovica Segat; Louise Kuhn; Sergio Crovella
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 3.  Nanomedicine as an emerging approach against intracellular pathogens.

Authors:  Andrea L Armstead; Bingyun Li
Journal:  Int J Nanomedicine       Date:  2011-12-09

4.  IL-18 Gene Promoter Region 607C/A Polymorphism in HIV-1 Infected North Indian Population.

Authors:  Rc Sobti; Vl Sharma; Am Abitew; N Berhane; Sa Mahdi; M Askari; Vs Kuttiat; A Wanchu
Journal:  Balkan J Med Genet       Date:  2011-12       Impact factor: 0.519

5.  Biomarkers of HIV Susceptibility and Disease Progression.

Authors:  Vanessa Pirrone; Joshua Mell; Benjamin Janto; Brian Wigdahl
Journal:  EBioMedicine       Date:  2014-11-07       Impact factor: 8.143

6.  Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran.

Authors:  Zahra Heydarifard; Alijan Tabarraei; Abdolvahab Moradi
Journal:  Dis Markers       Date:  2017-10-25       Impact factor: 3.434

7.  Analysis of transporter associated with antigen presentation (TAP) genes polymorphisms with HIV-1 infection.

Authors:  Abaineh Munshea Abitew; Ranbir Chander Sobti; Vijay Lakshmi Sharma; Ajay Wanchu
Journal:  Mol Cell Biochem       Date:  2019-11-16       Impact factor: 3.396

8.  Long term non-progressor (LTNP) HIV infection.

Authors:  Praveen Kumar
Journal:  Indian J Med Res       Date:  2013-09       Impact factor: 2.375

Review 9.  Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Authors:  Sylvia Fitting; MaryPeace McRae; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-02       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.